1. Roth, V. R.; Jarvis, W. R. Emerging Therapeutic Targets 1999, 3, 73. Niccolai, D.; Tarsi, L.; Thomas, R. J. Chem. Commun. 1997, 2333.
2. Isono, F.; Inukai, M. Antimicrob. Agents Chemother. 1991, 35, 234. Isono, F.; Inukai, M.; Takahashi, T.; Haneishi, T.; Kinoshita, T.; Kuwano, H. J. Antibiot. 1989, 42, 667. Brandish, P. E.; Kimura, K.-I.; Inukai, M.; Southgate, R.; Lonsdale, J. T.; Bugg, T. D. H. Antimicrob. Agents Chemother. 1996, 40, 1640. Inukai, M.; Isono, F.; Takatsuki, A. Antimicrob. Agents and Chemother. 1993, 37, 980. Isono, F.; Katayama, M.; Inukai, M.; Haneishi, T.; Kinoshita, T.; Kuwano, H. J. Antibiot. 1989, 62, 674. Brandish, P. E.; Burnham, M. K.; Lonsdale, J. T.; Southgate, R.; Inukai, M. J. Biol. Chem. 1996, 271, 7609.
3. An acid-labile linker for solid-phase oligoribonucleotide synthesis using Fmoc group for 5′-hydroxyl protection
4. Schöllkopf, U. Angew. Chem., Int. Ed. Engl. 1981, 20, 798; Williams, R. M. Synthesis of Optically Active α-Amino Acids; Pergamon Press: Oxford, 1989.